Compare Tapestry, Inc. (TPR) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tapestry, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Tapestry, Inc. trades at $116.09 (market cap $23.09B), while Zimmer Biomet Holdings Inc trades at $89.91 (market cap $16.95B). The key difference: Tapestry, Inc. is the larger of the two by market cap, and Tapestry, Inc. pays the higher dividend (1.6%). Which is the better fit depends on your goals — on Pluang, investors hold Tapestry, Inc. for 70 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| TPR | ZBH | |
|---|---|---|
Market Cap | $23.09B | $16.95B |
Volume | 2,745,259 | 2,505,240 |
Sector | Consumer Cyclical | Health |
52-Week High | $164.78 | $103.98 |
52-Week Low | $98.81 | $79.58 |
Typical Hold Time | 70 Days | 89 Days |
Enterprise Value | $25.89B | $24.02B |
Dividend Yield | 1.6% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TPR trades at $116.24, up 2.51% today, showing strong momentum after recent earnings beats. The stock faces technical resistance near $117-119 but maintains bullish analyst support with a $174.64 consensus target. Recent financials show revenue growth to $7.01B in 2025, though net income declined to $183M. The company benefits from strong brand performance with Coach driving growth, while expanding digital presence through Google partnerships.
Outlook remains positive with 73% analyst buy ratings and projected 2026 revenue of $8B. Key risks include Kate Spade execution challenges, tariff pressures, and premium valuation at 15.93 P/E. The stock offers 50% upside to consensus target but requires monitoring of margin expansion and international growth execution.
Zimmer Biomet (ZBH) trades at $89.14, up 0.73% today, with a bearish technical signal but strong recent earnings beats. The stock shows robust fundamentals with a 69.87% gross margin and 2025 revenue of $8.23B, though net income margin has declined from 2023 peaks. Analyst consensus is a Buy with a $103.11 target, indicating potential upside, supported by a steady dividend and institutional accumulation.
The outlook is mixed: valuation metrics like a P/E of 21.57 appear reasonable, and earnings momentum is positive, but technical weakness and rising debt-to-asset ratios pose risks. Investment appeal hinges on execution of commercial transformations and procedure volume recovery, balancing growth prospects against competitive and operational headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tapestry, Inc.
Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
